🟢 Crispr Therapeutics is trading 4.07% up today as risk appetite strengthens

Crispr Therapeutics is trading 4.07% up now at $58.86 as risk appetite strengthens across U.S. equities.

• The S&P 500 is up 1.02% and the Nasdaq Composite is up 1.61%; falling oil prices and Treasury yields are supporting sentiment.
• No new company-specific announcement clearly explains the September 21, 2026 move.
• Investor attention has centered on CASGEVY growth and upcoming pipeline data.